Standout Papers
Citation Impact
Citing Papers
The Effects of Growth Hormone and/or Testosterone in Healthy Elderly Men: A Randomized Controlled Trial
2006
Low Sex Hormone-Binding Globulin, Total Testosterone, and Symptomatic Androgen Deficiency Are Associated with Development of the Metabolic Syndrome in Nonobese Men
2006
Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase
2004 StandoutScience
Circulating microRNAs as stable blood-based markers for cancer detection
2008 Standout
Prevalence of Symptomatic Androgen Deficiency in Men
2007
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Serum testosterone but not leptin predicts mortality in elderly men
2008
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
2011 Standout
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
2020 Standout
A double-blind, placebo-controlled study of edivoxetine as an adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment
2014
Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle‐aged men: a meta‐analysis
2005
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring
2021 StandoutNobel
Low Testosterone Is Associated with Decreased Function and Increased Mortality Risk: A Preliminary Study of Men in a Geriatric Rehabilitation Unit
2004
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy‐induced nausea and vomiting
2010
Testosterone Use in Men With Sexual Dysfunction: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials
2007
Sex Steroids and All-Cause and Cause-Specific Mortality in Men
2007
Preoperative Supraphysiological Testosterone in Older Men Undergoing Knee Replacement Surgery
2002
Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone
2004
Effects of Testosterone on Behavior, Depression, and Cognitive Function in Older Men With Mild Cognitive Loss
2004
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Exogenous Testosterone (T) Alone or with Finasteride Increases Physical Performance, Grip Strength, and Lean Body Mass in Older Men with Low Serum T
2005
Prevalence of hypogonadism in males aged at least 45 years: the HIM study
2006
Correlates of physical activity: why are some people physically active and others not?
2012 Standout
Effect of Testosterone Replacement Therapy on Prostate Tissue in Men With Late-Onset Hypogonadism
2006
The World report on ageing and health: a policy framework for healthy ageing
2015 Standout
Review of the role of androgenic hormones in the epidemiology of benign prostatc hyperplasia and prostate cancer
1994
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Comparison of screening questionnaires for the diagnosis of hypogonadism
2005
Rapid worldwide depletion of predatory fish communities
2003 StandoutNature
Human and Chimpanzee Gene Expression Differences Replicated in Mice Fed Different Diets
2008 StandoutNobel
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
2004 Standout
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
2009
A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
2002
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
The Physical Activity Scale for the Elderly (PASE)
1999 Standout
Immunology and immunotherapy approaches for prostate cancer
2007
A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy
2006
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
1998 Standout
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
Aprepitant
2004
Maternal and child undernutrition: consequences for adult health and human capital
2008 Standout
Aspirin and cancer risk: a quantitative review to 2011
2012
Outcome instruments to measure frailty: A systematic review
2010
Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty
2004
Colorectal cancer
2013 Standout
Growth Hormone and Sex Steroid Effects on Bone Metabolism and Bone Mineral Density in Healthy Aged Women and Men
2002
Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study
1996
DHEA in Elderly Women and DHEA or Testosterone in Elderly Men
2006
The case for early detection
2003 Nobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions
2008 StandoutNature
Cellular Senescence and Tissue Aging In Vivo
2002
Effect of Testosterone Supplementation on Functional Mobility, Cognition, and Other Parameters in Older Men
2008
The Effects of Growth Hormone and Sex Steroid on Lean Body Mass, Fat Mass, Muscle Strength, Cardiovascular Endurance and Adverse Events in Healthy Elderly Women and Men
2003
The Influence of Finasteride on the Development of Prostate Cancer
2003 Standout
PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY
1997
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
2006 Standout
An investigation of antioxidant status, DNA repair capacity and mutation as a function of age in humans
1995
Bladder cancer
2016 Standout
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Stem cells, ageing and the quest for immortality
2006 StandoutNature
Long-term functional and oncological results after retroperitoneal laparoscopic prostatectomy according to a prospective evaluation of 550 patients
2006
Ontoaenetic correlates of diet in anthropoid primates
1994
The frail elderly functional assessment questionnaire: Its responsiveness and validity in alternative settings
1999
Sarcopenia
2019 Standout
Apoptosis in the aging process
2000
A randomized, double-blind study comparing LY2216684 and placebo in the treatment of major depressive disorder
2011
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
2002 Standout
Sexual dysfunction in men and women with endocrine disorders
2007
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
2011 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy
1995
Frailty: implications for clinical practice and public health
2019 Standout
Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends
2002
Effects of Testosterone on Cognition and Mood in Male Patients With Mild Alzheimer Disease and Healthy Elderly Men
2005
Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
2004
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Nutritional requirements and human evolution: A bioenergetics model
1992
Hormones and prostate cancer: Current perspectives and future directions
2002
The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study
2006
Maternal nutrition during gestation and blood pressure in later life
2001
Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2006
Prostate-specific antigen and radiation therapy for clinically localized prostate cancer
1995
Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan
2003
Low Free Testosterone Predicts Mortality from Cardiovascular Disease But Not Other Causes: The Health in Men Study
2011
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
2019
Simultaneous determination of Aprepitant and two metabolites in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection
2004
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Applications of Fourier transform infrared microspectroscopy in studies of benign prostate and prostate cancer. A pilot study
2003
Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men
2006
Frailty in elderly people
2013 Standout
Oral Testosterone Supplementation Increases Muscle and Decreases Fat Mass in Healthy Elderly Males With Low-Normal Gonadal Status
2003 Standout
Growth Hormone and Sex Steroid Administration in Healthy Aged Women and Men
2002
Evolutionary perspectives on human nutrition: The influence of brain and body size on diet and metabolism
1994
Older Men Are as Responsive as Young Men to the Anabolic Effects of Graded Doses of Testosterone on the Skeletal Muscle
2005
Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts Male Aging Study
2001
Testosterone Supplementation in Older Men: A Rational Idea Whose Time Has Not Yet Come
2001
Fluorine in medicinal chemistry
2007 Standout
RECURRENCE PATTERNS AFTER RADICAL RETROPUBIC PROSTATECTOMY: CLINICAL USEFULNESS OF PROSTATE SPECIFIC ANTIGEN DOUBLING TIMES AND LOG SLOPE PROSTATE SPECIFIC ANTIGEN
1997
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
TESTOSTERONE REPLACEMENT THERAPY AFTER PRIMARY TREATMENT FOR PROSTATE CANCER
2005
Cytochrome P4502C9 genotype in Southeast Anatolia and possible relation with some serum tumour markers and cytokines.
2001
Aging, Androgens, and the Metabolic Syndrome in a Longitudinal Study of Aging
2007
Integrating Person‐Centered and Variable‐Centered Analyses: Growth Mixture Modeling With Latent Trajectory Classes
2000 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Fifteen-Year Survival in Prostate Cancer<subtitle>A Prospective, Population-Based Study in Sweden</subtitle>
1997
Prostate Specific Antigen Best Practice Statement: 2009 Update
2009
Delayed Nausea and Vomiting Continue to Reduce Patients' Quality of Life After Highly and Moderately Emetogenic Chemotherapy Despite Antiemetic Treatment
2006
Electrochemiluminescence (ECL)
2004 Standout
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Evaluation and Treatment of Hypogonadism in Adult Male Patients—2002 Update
2002
Inverse Association of Testosterone and the Metabolic Syndrome in Men Is Consistent across Race and Ethnic Groups
2008
Utility, Limitations, and Pitfalls in Measuring Testosterone: An Endocrine Society Position Statement
2006
Frozen section diagnosis of metastatic prostate adenocarcinoma in pelvic lymphadenectomy compared with nomogram prediction of metastasis
2002
Cancer statistics, 2016
2016 Standout
Androgens and Coronary Artery Disease
2003
Cancer statistics, 2015
2015 Standout
Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?
2009
Low Testosterone is Associated with an Increased Risk of MACE Lethality in Subjects with Erectile Dysfunction
2010
Nonlinear Models for Repeated Measurement Data
1997
The Relative Contributions of Aging, Health, and Lifestyle Factors to Serum Testosterone Decline in Men
2006
A Linear Mixed-Effects Model with Heterogeneity in the Random-Effects Population
1996
Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study
2007
Cannabinoids for Medical Use
2015 Standout
Association of Specific Symptoms and Metabolic Risks with Serum Testosterone in Older Men
2006
Global cancer statistics, 2012
2015 Standout
Low Serum Testosterone and Mortality in Older Men
2007
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Dissociation of Oct-1 from the Nuclear Peripheral Structure Induces the Cellular Aging-associated Collagenase Gene Expression
1997
Correlates of Low Testosterone and Symptomatic Androgen Deficiency in a Population-Based Sample
2008
Generation times in wild chimpanzees and gorillas suggest earlier divergence times in great ape and human evolution
2012 StandoutNobel
Effects of Transdermal Testosterone on Bone and Muscle in Older Men With Low Bioavailable Testosterone Levels
2001
Works of Jay D. Pearson being referenced
The GRID-HAMD: standardization of the Hamilton Depression Rating Scale
2008
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
2001 Standout
Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases
1994
Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer
1996
RELIABILITY AND VALIDITY OF THE FRAIL ELDERLY FUNCTIONAL ASSESSMENT QUESTIONNAIRE
1995
Functional relevance of antiemetic control
2003
Age-Associated Changes in Blood Pressure in a Longitudinal Study of Healthy Men and Women
1997
Mixed‐effects regression models for studying the natural history of prostate disease
1994
Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity
1995
Prostate-Specific Antigen Testing of Older Men
1999
Longitudinal evaluation of serum androgen levels in men with and without prostate cancer
1995
Estimation of energy expenditure in Western Samoa, American Samoa, and Honolulu by recall interviews and direct observation
1990
Altered transcriptional regulation of human interstitial collagenase in cultured skin fibroblasts from older donors
1994
PROSTATE-SPECIFIC ANTIGEN VELOCITY AND REPEATED MEASURES OF PROSTATE-SPECIFIC ANTIGEN
1997
Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index?Emesis (FLIE) with 5-day recall
2003
Basal DNA damage in individual human lymphocytes with age
1991
Natural History of Changes in Prostate Specific Antigen in Early Stage Prostate Cancer
1994
PSA VELOCITY FOR THE DIAGNOSIS OF EARLY PROSTATE CANCER
1993
Ecological significance of hypometabolism in nonhuman primates: Allometry, adaptation, and deviant diets
1986
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
1997
Nonsteroidal Anti-inflammatory Drugs and Risk of Prostate Cancer in the Baltimore Longitudinal Study of Aging
2005
Estimating Unknown Transition Times Using a Piecewise Nonlinear Mixed-Effects Model in Men with Prostate Cancer
1995
Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium
2001
Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease.
1992
Estimating Unknown Transition Times Using a Piecewise Nonlinear Mixed-Effects Model in Men with Prostate Cancer
1995
VALIDATION OF PARTIN TABLES FOR PREDICTING PATHOLOGICAL STAGE OF CLINICALLY LOCALIZED PROSTATE CANCER
2000